Yiwen Tao

This inventor holds 9 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Bayer Pharmaceuticals Corporation, La Jolla Biologics, Inc., Bayer Healthcare LLC. Active years: 2007-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yiwen Tao. Retrieved from https://idiyas.com/inventor/yiwen-tao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 2)

% Patents Active = 88.9

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 17(Granted Patents)

Location History:

Albany, CA (US) (2007 - 2013)
San Diego, CA (US) (2014 - 2020)

Company Filing History:

6 out of 71

Bayer Pharmaceuticals Corporation

patents

2 out of 2

La Jolla Biologics, Inc.

Years Active: 2007-2024

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12173049 - Cell culture medium (2024-12-24),

2. 10703800 - Cell culture medium (2020-07-07),

3. 9284591 - Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells (2016-03-15),

4. 8772027 - Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells (2014-07-08),

5. 8765466 - Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells (2014-07-01),

6. 8409857 - Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells (2013-04-02),

7. 8192985 - Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells (2012-06-05),

8. 7951588 - Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells (2011-05-31),

9. 7244616 - Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells (2007-07-17),

Title: Yiwen Tao: Innovator in Cell Culture Technology

Introduction

Yiwen Tao is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of cell culture technology. With a total of 9 patents to his name, he has made remarkable advancements that enhance the efficiency and effectiveness of mammalian cell cultures.

Latest Patents

One of Yiwen Tao's latest patents focuses on a novel cell culture medium. This invention provides compositions and methods for culturing mammalian cells, incorporating a lithium ion source, fatty acids, and ethanol. The use of this specialized medium has been shown to improve the production of recombinant polypeptides, such as antibodies, resulting in increased titers and a more favorable glycosylation profile. Additionally, it modulates the amounts of high and low molecular weight species, as well as acidic or basic charge variants, compared to traditional culture media.

Career Highlights

Throughout his career, Yiwen Tao has worked with notable companies, including Bayer Pharmaceuticals Corporation and La Jolla Biologics, Inc. His experience in these organizations has allowed him to refine his expertise in biopharmaceutical development and cell culture methodologies.

Collaborations

Yiwen has collaborated with talented individuals in his field, including Sham-Yuen Chan and Hsinyi Yvette Tang. These partnerships have contributed to the innovative research and development of cell culture technologies.

Conclusion

Yiwen Tao's work in cell culture technology exemplifies the impact of innovation in the biopharmaceutical industry. His patents and collaborations continue to advance the field, paving the way for improved therapeutic solutions.

Profile summary based on public USPTO records.